Taro Pharma CEO Kal Sundaram has stepped down

Posted on:09 Jul 2016 09:31:12

Taro Pharma CEO Kal Sundaram has stepped down
09 July 2016 Current Affairs: Taro Pharmaceutical Industries Ltd. has announced that its CEO, Mr. Kal Sundaram, has stepped down. He will return to India, to assume an executive position at Sun Pharma’s global headquarters after the completion of his assignment at Taro at the end of 2016.

Taro Pharmaceutical is the US arm of Sun Pharma. Sun Pharma acquired a controlling stake in Taro in 2010. The Company’s Board will conduct a formal process to appoint a CEO to solely focus on Taro. Mr. Sundaram will assist the Board with its search, and will remain with Taro through the end of 2016 to ensure a smooth and successful transition for his successor.

Kal Sundaram, also known as Kalyanasundaram Subramanian, became CEO of Taro in April 2012. He had been Sun Pharma’s CEO since April 2010 and played a role in accelerating the company’s growth in India and other emerging markets.

 Sundaram has almost three decades of experience, much of which has been in the pharmaceutical industry, largely with GlaxoSmithKline Plc. (GSK), where he has held the country, regional and global responsibilities. Sundaram left GSK India as its managing director.


Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs July 2017

27 JULY
NEWS
26 JULY
NEWS
25 JULY
NEWS
24 JULY
NEWS

Current Affairs June 2017

30 JUNE
NEWS
29 JUNE
NEWS
28 JUNE
NEWS
27 JUNE
NEWS

Current Affairs May 2017

31 MAY
NEWS
30 MAY
NEWS
29 MAY
NEWS
27 MAY
NEWS